0000905718-16-001753.txt : 20161114 0000905718-16-001753.hdr.sgml : 20161111 20161114165236 ACCESSION NUMBER: 0000905718-16-001753 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161114 DATE AS OF CHANGE: 20161114 EFFECTIVENESS DATE: 20161114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TYNDALL CAPITAL PARTNERS L P CENTRAL INDEX KEY: 0001219314 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10427 FILM NUMBER: 161995688 BUSINESS ADDRESS: STREET 1: 405 PARK AVENUE STREET 2: SUITE 1104 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-446-2473 MAIL ADDRESS: STREET 1: 405 PARK AVENUE STREET 2: SUITE 1104 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001219314 XXXXXXXX 09-30-2016 09-30-2016 false TYNDALL CAPITAL PARTNERS L P

405 Park Avenue Suite 1104 New York NY 10022

13F HOLDINGS REPORT 028-10427 N Jeffrey S. Halis 212-446-2460 /s/ Jeffrey S. Halis New York NY 11-14-2016 0 2 1844 true INFORMATION TABLE 2 infotable.xml ONCONOVA THERAPEUTICS INC COM NEW 68232V306 1453 520832 SH SOLE 520832 0 0 ONCONOVA THERAPEUTICS INC *W EXP 07/07/202 68232V116 391 390624 SH SOLE 390624 0 0